The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2021 | Key transplantation updates at EHA 2021
Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, talks on key updates in the field of stem cell transplantation at EHA 2021, in particular highlighting a study which investigated the prediction of transplantation outcomes in acute lymphoblastic leukemia (ALL) using a novel scoring system which incorporated disease status, phenotype and measurable residual disease (MRD) assessment. Prof. Nagler also comments on advances in the management of graft-versus-host disease (GvHD) and novel drugs for the prevention of relapse after transplantation. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.
